Drug Research

Wheeler Bio, Inc., a CDMO specializing in process development and small batch cGMP production of therapeutic antibodies, announced the closing of their Series A financing round. The company will use the funding to complete its state-of-the-art cGMP cell banking...

Araris Biotech AG, a company pioneering a proprietary antibody-drug conjugate (ADC)-linker technology,announced that Samsung Venture Investment Corporation (“Samsung Ventures”), an investment corporation established to promote the development of new technologies, has invested in the Company in an independent deal...

The Center for Breakthrough Medicines (CBM), a contract development and manufacturing organization (CDMO) dedicated to addressing critical challenges associated with the commercialization of cell and gene therapies, has completed a successful technology transfer of the University of Pennsylvania Gene...

Cancer happens to be a leading cause of global death and accounts for almost one in six fatalities, with metastatic cancers contributing more than 90% of the overall cancer-related deaths. Apparently, metastatic cancers take place when the cancer cells...

A malaria vaccine called R21/Matrix-M, which was developed in collaboration with the University of Oxford as well as a manufacturer of vaccines and immunological products from India, has been given the licence to be used in Ghana by the...

A worldwide consortium that comprises biomedical researchers co-led by Alexander Bick, MD, PhD, at the Vanderbilt University Medical Centre, has come up with a new way to gauge the precancerous clones of blood stem cells that would go on...

Bora Pharmaceuticals Co., Ltd. and Celltrion Asia Pacific Pte., Ltd. , a subsidiary of Celltrion Group Inc, have announced their partnership to contract manufacture and commercialize a range of oral dosage form drugs (OSD) across the APAC region. The range...